Abstract
The aim of this study was to examine the relationship between health-related quality of life and brain-tumor related posttraumatic
stress symptoms (PTSS) in adults who had been treated for a primary benign meningioma (MGM). Utilizing a cross-sectional survey
design, 70 adults who had previously been treated with radiotherapy [M = 4.4 years] for a benign MGM were administered questionnaires
assessing MGM-related PTSS, health-related quality-of-life (QOL), and current mood, as well as a test of executive functioning.
Sixteen percent of the sample reported heightened MGM-related PTSS. Elevated PTSS was significantly associated with a substantial
reduction in executive functioning, QOL, as well as heightened symptoms of depression, fatigue and confusion. The majority
of participants with elevated PTSS reported the need to have professional support due to feeling distressed and having a fear
of their tumor progressing or recurring. The findings suggest that one in six patients treated for a benign MGM are at risk
of experiencing MGM-related PTSS both in the short- and longer-term, and PTSS may seriously hamper patients QOL irrespective
of prognosis. The findings suggest that psychological effects need to be taken into account when treating MGM patients.
stress symptoms (PTSS) in adults who had been treated for a primary benign meningioma (MGM). Utilizing a cross-sectional survey
design, 70 adults who had previously been treated with radiotherapy [M = 4.4 years] for a benign MGM were administered questionnaires
assessing MGM-related PTSS, health-related quality-of-life (QOL), and current mood, as well as a test of executive functioning.
Sixteen percent of the sample reported heightened MGM-related PTSS. Elevated PTSS was significantly associated with a substantial
reduction in executive functioning, QOL, as well as heightened symptoms of depression, fatigue and confusion. The majority
of participants with elevated PTSS reported the need to have professional support due to feeling distressed and having a fear
of their tumor progressing or recurring. The findings suggest that one in six patients treated for a benign MGM are at risk
of experiencing MGM-related PTSS both in the short- and longer-term, and PTSS may seriously hamper patients QOL irrespective
of prognosis. The findings suggest that psychological effects need to be taken into account when treating MGM patients.
- Content Type Journal Article
- Pages 1-20
- DOI 10.1007/s11482-011-9159-1
- Authors
- Maria Kangas, Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney, 2109 Australia
- Janet R. Williams, The Prince of Wales Cancer Centre, Prince of Wales Hospital, Sydney, Australia
- Robert I. Smee, The Prince of Wales Cancer Centre, Prince of Wales Hospital, Sydney, Australia
- Journal Applied Research in Quality of Life
- Online ISSN 1871-2576
- Print ISSN 1871-2584